Westport Fuel Systems (WPRT) Receives a Buy from Craig-Hallum
Confident Investing Starts Here:
Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Stine covers the Industrials sector, focusing on stocks such as Electrovaya, Ameresco, and American Superconductor. According to TipRanks, Stine has an average return of 0.2% and a 32.39% success rate on recommended stocks.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Westport Fuel Systems with a $5.50 average price target.
The company has a one-year high of $6.60 and a one-year low of $2.50. Currently, Westport Fuel Systems has an average volume of 29.71K.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
22 minutes ago
- Business Insider
M&A News: Peabody Stock (BTU) Is Shelled as it Scraps $3.8B Anglo American Coal Deal
Shares in coal giant Peabody Energy (BTU) collapsed nearly 2% today as it scrapped its planned $3.8 billion acquisition of Anglo American's (NGLOY) Australian coking coal assets. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Fire Alert Peabody had agreed to buy the mines based in Queensland's Bowen Basin but changed its mind after an underground fire halted operations at the Moranbah North mine in March. The fire was reportedly caused by high gas levels at the site. However, in its statement today Peabody said that the exact cause of the event remains unknown, with no definitive timeline to resuming production at the site. Peabody had invoked a clause allowing it to walk away from the deal – which had been due to close in April – or renegotiate if a major adverse event, like the fire, took place between the signing of the deal and completion. 'The two companies did not reach a revised agreement to cure the MAC (material adverse change) that compensated Peabody for the material and long-term impacts of the MAC on the most significant mine in the planned acquisition,' said Peabody President and Chief Executive Officer Jim Grech. Arbitration Fight Anglo, which is selling or spinning off assets following rival BHP's (BHP) failed takeover attempt last year, said that it would 'shortly initiate an arbitration to seek damages for wrongful termination,' disputing that the fire and mine closure constituted a material adverse change, due to the lack of damage to the mine or equipment and progress made towards restarting it. 'We are therefore very disappointed that Peabody has decided not to complete the transaction,' said Anglo's CEO Duncan Wanblad. However, he added that given strong interest for the assets during the bidding process, he is confident an alternative buyer can be found through a new sales process. As seen above, Peabody stock is down 18% in the year-to-date hit by weaker global coal prices, the global economy and uncertainty over President Trump's tariff strategy. The long-term picture for coal producers is also murky given the push to cleaner energy supplies. Is BTU a Good Stock to Buy Now? On TipRanks, BTU has a Moderate Buy consensus based on 3 Buy and 2 Hold ratings. Its highest price target is $23. BTU stock's consensus price target is $18.66, implying a 9.83% upside.
Business Insider
23 minutes ago
- Business Insider
Citi Reaffirms Their Buy Rating on Seek Limited (SKLTF)
In a report released today, Siraj Ahmed from Citi maintained a Buy rating on Seek Limited, with a price target of A$28.50. The company's shares closed last Tuesday at $15.81. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Ahmed is a 5-star analyst with an average return of 12.0% and a 61.00% success rate. Ahmed covers the Technology sector, focusing on stocks such as Wisetech Global, Nextdc Limited, and Xero Limited. In addition to Citi, Seek Limited also received a Buy from Jefferies's Roger Samuel in a report issued today. However, on the same day, Goldman Sachs maintained a Hold rating on Seek Limited (Other OTC: SKLTF). The company has a one-year high of $19.95 and a one-year low of $10.33. Currently, Seek Limited has an average volume of 418.
Business Insider
an hour ago
- Business Insider
Medtronic Stock (MDT) Slides Despite Corporate Re-Jig to Boost Ailing Valuation
Shares in medical technology group Medtronic (MDT) lost ground today after a corporate reshuffle aimed at boosting M&A. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to a report in the Wall Street Journal, activist investor Elliott Investment Management has become one of the group's largest shareholders. This followed a series of so-called friendly talks between the pair focused on boosting the company's valuation – currently $119 billion – and how to concentrate on core assets. The exact size of Elliott's previously undisclosed stake is not known. Veteran Directors It is understood that when Medtronic announces its first quarter results later on Tuesday, August 19, it will reveal that veteran med-tech executives John Groetelaars and Bill Jellison will be joining its board as independent directors. It is also expected to detail the formation of new special committees focused on growth and operations that will include the new directors and be led by Medtronic chief executive Geoff Martha. One of the new committees will look for so-called tuck-in M&A opportunities, research and development investments and potential divestitures. The other will look for ways to boost earnings growth. Undervalued Stock Medtronic develops, manufactures and distributes medical devices and therapies that treat more than 70 health conditions, from Parkinson's to diabetes. The company, which is based in Ireland but has its operational headquarters in Minneapolis, has seen its shares rise more than 16% so far this year. However, the company is still seen as undervalued, especially for being the biggest med-tech company globally by revenue. Medtronic booked more than $32 billion in revenue in 2024. In comparison Boston Scientific (BSX), with a larger market value of almost $153 billion, reported about $17 billion in sales last year. Its share price performance is also trailing. The company has already been making moves to boost its value. It has focused on innovations such as how to treat atrial fibrillation, which has been a huge growth spot in the industry. It is also planning a separation of its diabetes business into a stand-alone group. Is MDT a Good Stock to Buy Now? On TipRanks, MDT has a Moderate Buy consensus based on 13 Buy, 12 Hold and 1 Sell ratings. Its highest price target is $109. MDT stock's consensus price target is $98.44, implying a 6.07% upside. See more MDT analyst ratings
